Genotype and visceral adiposity interactions on hepatic steatosis in Mexican adults
Journal of the Endocrine Society · 2026-11-02 · 10 (12)
DOI: 10.1210/jendso/bvag249 ↗Abstract
Abstract Background The SLC16A11 haplotype has been associated with type 2 diabetes (T2D) in populations with high Native American ancestry; however, its role in hepatic outcomes remains uncertain. We evaluated the association of rs13342232 with noninvasive liver markers and whether visceral adiposity tissue (VAT) modifies this relationship in Mexican adults with and without T2D. Methods We included 607 adults (non-T2D, n = 256; T2D, n = 351) with genotype, VAT, and fatty liver index (FLI) data. Hepatic steatosis was additionally assessed using FibroScan-derived controlled attenuation parameter and steatosis grade in 301 participants. Multivariable regression models with VAT × rs13342232 interaction terms were fitted, adjusting for ancestry principal components. Results A significant VAT × G/G interaction on FLI was observed in the full sample (β = 3.19, 95% CI 0.23-6.15; P = .035). The interaction was markedly stronger in adults without T2D (β = 7.51, 95% CI 1.23-13.78; P = .018) than in those with T2D (β = 2.00, 95% CI −0.43 to 4.42; P = .105), suggesting that the gene–environment effect is most clearly expressed before diabetes onset. Null findings for both the A/G interaction and the dominant model in the non-T2D stratum support a recessive inheritance pattern. FibroScan validation confirmed a VAT × G/G interaction on steatosis grade in non-T2D participants (β = .50, 95% CI 0.01-0.99; P = .044). In the T2D stratum, a significant negative A/G × VAT interaction was observed (β = −1.63, P = .046), indicating heterozygote attenuation of the VAT–steatosis relationship. Conclusion The SLC16A11 rs13342232 G/G genotype amplifies the hepatic steatosis response to visceral adiposity in Mexican adults. This effect is strongest prior to diabetes onset, supporting a gene–environment interaction in hepatic fat accumulation.
EUVIMED